Short answer: Phage display is a laboratory selection method in which a peptide or protein is fused to a coat protein of a bacteriophage, so each virus particle carries that peptide on its surface while still carrying the DNA that encodes it [3]. Because every clone physically links what is displayed (the peptide) to its own gene, a mixed library of many different clones can be sorted by binding, then amplified and sequenced [3]. George P. Smith described the method in 1985, and it was recognized with a share of the 2018 Nobel Prize in Chemistry [1][4].
This article is educational chemistry and molecular biology for laboratory readers. It describes a screening technique, not effects in people or animals, and is not guidance for human or animal use.
The 1985 experiment
Smith's original report showed that foreign DNA fragments can be inserted into filamentous phage gene III to create a fusion protein with the foreign sequence in the middle [1]. Three things made it useful:
- The fusion protein is incorporated into the virion, so the foreign amino acids sit on the outside of the particle in an immunologically accessible form [1].
- The particle stays infective, so it can still be grown in bacteria after it has been handled [1].
- These "fusion phage" could be enriched more than 1,000-fold over ordinary phage by affinity for an antibody directed against the foreign sequence [1].
Why the genotype-phenotype link matters
A peptide sitting alone in a tube tells you nothing about where it came from once it is mixed with millions of others. Phage display solves that bookkeeping problem physically. The displayed peptide and the DNA encoding it travel inside the same particle, so a library of clones can be screened by affinity purification and the winners can be read out by sequencing their DNA rather than by sequencing the peptide itself [3].
Scott and Smith made that concrete in 1990 with what they called an epitope library: a vast mixture of filamentous phage clones, each displaying one peptide sequence on the virion surface, in which tens of millions of short peptides can be surveyed for tight binding to an antibody, receptor or other binding protein [2]. Phage that display tight-binding peptides are affinity-purified with the binding protein and propagated in Escherichia coli, and the amino acid sequences are then determined by sequencing the corresponding coding region in the viral DNA [2].
Biopanning, step by step
The affinity selection cycle has a name of its own: biopanning. A review of peptide phage display describes the standard loop [3]:
- The display library is incubated with an immobilized target.
- Extensive washing removes nonreacting phages.
- Binders are eluted, usually with acid or high salt.
- The eluted phage are enriched by amplification in the appropriate host cells.
- Three to five rounds are usually performed to obtain binders with high affinity.
- The primary structure of the selected peptide is determined by sequencing the DNA of individual clones.
Panning on cells instead of purified protein
Targets do not have to be purified proteins stuck to a plate. Using whole cells has real advantages: receptors expressed on live cells can retain their native states, including correct folding, quaternary structure, expression level and association with neighboring proteins, along with their biological activities [3].
Protocol variations then let you choose what kind of binder you keep. Direct elution isolates surface-bound phage, while removing surface-bound phage with low-pH washes or protease treatment leaves the clones that were internalized [3].
What the method is used for
The same review groups published uses of phage-displayed peptide libraries into three broad areas [3]:
- B-cell and T-cell epitope mapping.
- Selection of peptides that bind receptors or other proteins, antigen mimics, peptides bound to non-protein targets, and cell- or organ-specific peptides.
- Development of peptide-mediated delivery systems and related applications.
The Nobel recognition
In 2018 the Royal Swedish Academy of Sciences awarded one half of the Nobel Prize in Chemistry to Frances H. Arnold for the directed evolution of enzymes, and the other half jointly to George P. Smith and Sir Gregory P. Winter "for the phage display of peptides and antibodies" [4]. The Academy's summary credits Smith with developing the method in 1985 and Winter with using phage display for the directed evolution of antibodies [4].
How it relates to peptide chemistry
Phage display is a biological production route, not a chemical one, and that is its main limit for peptide work. The displayed sequence has to be something a bacterium can translate from DNA, so a library is built from the standard genetically encoded residues. Chemical routes such as solid-phase peptide synthesis are what let a chemist install D-amino acids, unnatural side chains or defined post-translational modifications at chosen positions, and ligation chemistry such as native chemical ligation is what joins synthetic fragments into whole proteins. In practice the two toolkits sit next to each other: display finds a sequence, chemistry rebuilds and modifies it.
Common questions
What is phage display in one sentence?
It is a selection technique in which a peptide or protein is fused with a bacteriophage coat protein and displayed on the surface of a virion, so binding clones can be separated from nonbinding ones and identified by their DNA [3].
Which phage gene did Smith use?
Gene III of filamentous phage; the foreign sequence was placed in the middle of the resulting fusion protein [1][3].
How large can a peptide library be?
The 1990 epitope library paper describes surveying tens of millions of short peptides for tight binding in a single experiment [2].
How many rounds of panning are typical?
Three to five rounds are usually performed to pull out high-affinity binders [3].
How is the winning sequence identified?
By sequencing the coding region in the phage DNA of individual clones, not by sequencing the peptide itself [2][3].
Bottom line
Phage display works because one virus particle carries both a displayed peptide and the gene for it [3]. Smith showed in 1985 that a fusion into gene III keeps the phage infective and lets antibody affinity enrich it more than 1,000-fold [1]; Scott and Smith showed in 1990 that the same trick scales to libraries of tens of millions of peptides [2]; and three to five rounds of bind-wash-elute-amplify remain the standard way to find a binder today [3].
All products are for research use only — not for human or animal consumption.
